Related Experiment Video
Updated: May 21, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative
Juana V Martín-López1, Ysamar Barrios, Vicente Medina-Arana
1Unidad de Investigación Mixta HUC-ULL, Facultad de Medicina, Universidad de La Laguna, La Laguna, Santa Cruz de Tenerife, 38002, Spain.
A founder mutation in the hMSH2 gene, hMSH2(M688R), is linked to Lynch syndrome and a high incidence of central nervous system tumors. This mutation impairs DNA mismatch repair, potentially acting as a dominant negative factor.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Lynch syndrome (LS/HNPCC) is associated with mismatch repair (MMR) gene mutations.
- Some LS/HNPCC families exhibit unusual central nervous system (CNS) tumors, typical of Turcot or CMMR-D syndromes.
- The hMSH2(M688R) mutation, found in Spanish families, is a potential founder mutation for LS/HNPCC.
Purpose of the Study:
- To investigate the functional impact of the hMSH2(M688R) mutation on MMR.
- To determine if hMSH2(M688R) contributes to the observed tumor spectrum, including CNS tumors.
- To differentiate the pathogenicity of hMSH2(M688R) from the hMSH2(M688I) alteration.
Main Methods:
- In vitro analysis of hMSH2(M688R)-hMSH6 heterodimer function.
- Assessment of ATP binding and hydrolysis activity of the mutated heterodimer.
- Comparison of hMSH2(M688R) and hMSH2(M688I) heterodimers with wild-type (WT) counterparts.
Main Results:
- The hMSH2(M688R) heterodimer binds mismatched nucleotides but lacks normal ATP function.
- hMSH2(M688R) inhibits wild-type MMR in vitro and may act as a dominant negative.
- hMSH2(M688I) heterodimer shows no functional difference from WT, suggesting it is benign.
Conclusions:
- The hMSH2(M688R) mutation is a likely dominant-negative founder mutation contributing to LS/HNPCC and CNS tumors.
- Tumor expression variability and MSI in some hMSH2(M688R) carriers support a dominant-negative mechanism.
- The hMSH2(M688I) alteration is likely a non-pathogenic polymorphism.
Related Concept Videos
Abnormal Proliferation
Hedgehog Signaling Pathway
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

